Abstract
This opinion article reports a pioneering effort in its field, indicating the potential of conotoxins as pharmacological agents for anti-adhesion adjunct therapy in the context of malaria. In a similar vein, the potential application of conotoxins as inhibitors of protein-protein interactions holds promise for the mitigation of emerging diseases such as AIDS and COVID- 19.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
